Sclerostin-Antibody Treatment Decreases Fracture Rates in Axial Skeleton and Improves the Skeletal Phenotype in Growing oim/oim Mice
Mickaël Cardinal, Alicia Dessain, Thomas Roels, Sébastien Lafont, Michael S. Ominsky, Jean‐Pierre Devogelaer, Daniel Chappard, Guillaume Mabilleau, Patrick Ammann, Catherine Behets, Daniel Manicourt
Topics & Concepts
SclerostinQuantitative computed tomographyLumbar vertebraeOsteoporosisPelvisMedicineBone densityRib cageOsteogenesis imperfectaAnatomyInternal medicineChemistryLumbarWnt signaling pathwayGeneBiochemistryConnective tissue disorders researchBone health and osteoporosis researchBone Metabolism and Diseases